lystn

At the beginning of the pandemic, the prevailing theory was that people with eczema would be at higher risk for COVID-19 infection and impacts because so many are using steroid treatments and also suffer from asthma, which many guessed would make respiratory infections worse. But, in a rare bit of good news, the exact opposite may be true! Tune in to learn how the immune system abnormalities associated with eczema may actually protect against COVID-19 infection and how one treatment may reduce the risk of severe symptoms after infection. Our guests are Dr. Emma Guttman-Yassky, Professor of Dermatology and Immunology at the Icahn School of Medicine at Mount Sinai; Dr. Benjamin Ungar Assistant Professor of Dermatology also at Mount Sinai; and Dr. Adrian Martineau Professor of Respiratory Infection and Immunity Sciences in the School of Medicine at Queen Mary University of London. Research referenced in this episode: https://www.jaci-inpractice.org/article/S2213-2198(21)01203-4/fulltext (COVID-19 Symptoms in Patients Treated with Dupilumab) https://thorax.bmj.com/content/early/2021/11/02/thoraxjnl-2021-217487 (Risk factors for developing COVID-19) Support this podcast